Actimed.png
Actimed Therapeutics Appoints Martin Walton as Chief Financial Officer
19 oct. 2023 03h00 HE | Actimed Therapeutics
London, UK – 19th October 2023. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and...
BWR Resources.jpg
BWR Exploration Inc. Announces Jean-David Moore as an Advisor and Robert Suttie as Chief Financial Officer and the Grant of Stock Options
18 oct. 2023 17h00 HE | BWR Exploration Inc.
TORONTO, Oct. 18, 2023 (GLOBE NEWSWIRE) -- BWR Exploration Inc. (TSX.V: BWR) (“BWR” or the “Company”) is pleased to announce the appointment of Mr. Jean-David Moore as an Advisor to the Company. ...
BANXA Logo.jpg
Banxa Announces Key Board Changes
16 oct. 2023 07h59 HE | Banxa Holdings Inc.
This news release is intended for distribution only in Canada and is not intended for distribution to US newswire services, or for release, publication, or distribution in whole or in part, in or in...
Sound Bioventures.png
Sound Bioventures appoints Fredrik Lehmann as its first Entrepreneur-in-Residence
13 oct. 2023 03h00 HE | Sound Bioventures
Stockholm, Sweden and Cambridge, MA, USA – 13 October 2023 - Sound Bioventures, a venture capital fund investing in about-to-be clinical or clinical stage private companies in Europe and the USA...
Yves Bernaert est no
Yves Bernaert est nommé Directeur Général d'Atos
04 oct. 2023 02h30 HE | Atos International
Paris, France – 4 octobre, 2023 - Le Conseil d’administration d’Atos, réuni le 3 octobre 2023, suivant les recommandations du Comité des Nominations et de Gouvernance, a nommé Yves Bernaert Directeur...
Yves Bernaert is app
Yves Bernaert is appointed Chief Executive Officer of Atos
04 oct. 2023 02h30 HE | Atos International
Paris, France – October 4, 2023 - Atos's Board of Directors, at its meeting held on October 3rd, 2023, following the recommendations of the Nominations and Governance Committee, has appointed Yves...
Ajustement de la com
Ajustement de la composition du Conseil d'administration
04 oct. 2023 01h30 HE | Atos International
Paris, France – 4 octobre 2023 - Caroline Ruellan a décidé de démissionner du Conseil d'administration. Elle a été remplacée en tant que membre du Comité des Nominations et de Gouvernance par Carlo...
Adjustment in the co
Adjustment in the composition of the Board of Directors
04 oct. 2023 01h30 HE | Atos International
Paris, France – October 4, 2023 - Caroline Ruellan has decided to resign from the Board of Directors. She was replaced as member of the Nomination and Governance Committee by Carlo d'Asaro Biondo. ...
Picture2
TessPay Announces Appointment of its New Board Members
03 oct. 2023 08h47 HE | TessPay Inc.
TessPay is excited to announce its Board of Directors – Sept. 26, 2023 FORT MYERS, FL, Oct. 03, 2023 (GLOBE NEWSWIRE) -- TessPay Inc., (the “Company” or “TessPay”), operator of a blockchain-based...
Birchtree Investments Ltd. Announces Appointment of New Chief Financial Officer and Option Grant
02 oct. 2023 16h00 HE | Birchtree Investments Ltd.
VANCOUVER, British Columbia, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Birchtree Investments Ltd. (“Birchtree” or the “Company”) (CSE: BRCH), an investment company with the long-term goal of divesting its...